MOHAMMAD NAEEM: Open Payments
NPI 1811253420 · MANDEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 27 payments from 6 companies in 2025. Trend: 2023 $1,112 · 2024 $515 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $158 |
| ABBVIE INC. | 11 | $157 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, Auvelity, TRINTELLIX, REXULTI, FANAPT.
Industry payments across LA — which companies pay providers there.
